Aspect to develop 3D bioprinted knee meniscus

Image from Aspect Biosystems video: "Aspect Biosystems: The Bioprinting Process"

Aspect Biosystems Ltd., a specialist in the field of 3D bioprinting and tissue engineering, has recently entered into research collaboration with DePuy Synthes Products Inc. Under the agreement, facilitated by Johnson & Johnson Innovation, Aspect’s proprietary Lab-on-a-Printer™ 3D bioprinting platform will be used to develop bioprinted knee meniscus tissue suitable for surgical therapy. “We are very excited to work with a global healthcare leader like DePuy Synthes” said Tamer Mohamed, President and CEO of Aspect Biosystems. “This collaboration marks a significant step for Aspect to apply our 3D bioprinting platform technology in developing groundbreaking tissue replacement therapies that hold the real potential to improve quality of life for patients.”